Seelos Therapeutics Announces Acquisition of an Exclusive License to Intellectual Property from The UC Regents Biotech Investing
Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam to Treat Moderate-to-Severe Acne Pharmaceutical Investing
Pivot Completes C$1.1 Million Non-Brokered Private Placement and Loan Facility Pharmaceutical Investing
Naturally Splendid Announces Launch of NATERA(TM) Sports Bites and Sponsorship Deal With The Professional Golfers Association of BC Cannabis Investing News
Zealand Pharma Doses First Patient in Phase 3 Trial with Dasiglucagon for Treatment of Congenital Hyperinsulinism Pharmaceutical Investing
Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy Pharmaceutical Investing
Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia Pharmaceutical Investing
